Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Melanoma 21Breast Neoplasms 19Prostatic Neoplasms 12Neuroblastoma 11Multiple Myeloma 11Leukemia 11Leukemia, Myeloid, Acute 10Lymphoma 9Lymphoma, Non-Hodgkin 8Leukemia, Lymphocytic, Chronic, B-Cell 8Breast Neoplasms, Male 8Glioblastoma 7Ovarian Neoplasms 6Myelodysplastic Syndromes 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasm Metastasis 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Fallopian Tube Neoplasms 5Colorectal Neoplasms 5Neoplasms 4Lymphoma, Follicular 4Leukemia, Myeloid, Chronic-Phase 4Hodgkin Disease 4Glioma 4Carcinoma, Ovarian Epithelial 4Uveal Melanoma 3Rhabdomyosarcoma 3Pancreatic Neoplasms 3Medulloblastoma 3Lung Neoplasms 3

Interventions

Gemcitabine 79Cisplatin 56pembrolizumab 32Paclitaxel 28Carboplatin 24Docetaxel 19Radiotherapy 17Mitomycin 16Doxorubicin 15atezolizumab 14BCG Vaccine 14Nivolumab 13Cystectomy 13Filgrastim 11vinflunine 10Methotrexate 10Vinblastine 9Fluorouracil 95-aminolevulinic acid hexyl ester 9Sunitinib 7Early Intervention, Educational 7durvalumab 6avelumab 6Taxes 6Methods 6Cystoscopy 6Albumin-Bound Paclitaxel 6enfortumab vedotin 5Trastuzumab 5Surveys and Questionnaires 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Urinary Bladder Neoplasms × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT00070070 2022-10-12

Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas

Ludwig Institute for Cancer Research

Phase 1 Completed
6 enrolled 7 charts
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡